CIK 0001812364
- Large accelerated filer
Relay Therapeutics, Inc.
Sign in to watch- Ticker
- RLAY
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-370-8837
- Business address
- 60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
- 4 Open-market sale Chief Financial Officer sold 13,286 shares at $30.00 ($398,580)
- 4 Open-market sale President, R&D sold 10,000 shares at $30.00 ($300,000)
- 4 Open-market sale President, R&D sold 10,000 shares at $25.00 ($250,000)
- 4 Open-market sale President, R&D sold 8,000 shares at $23.88 ($191,040)
- 4 Open-market sale President, R&D sold 22,994 shares at an average $20.94 ($481,577)
- 4 Grant or award Chief Administrative Officer acquired 24,170 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Financial Officer acquired 39,270 shares (grant or award)
- 4 Grant or award President, R&D acquired 64,950 shares (grant or award)
- 4 Grant or award Chief Legal Officer acquired 39,270 shares (grant or award)
- 4 Grant or award General Counsel acquired 658 shares (grant or award)
- 4 Grant or award President and CEO acquired 658 shares (grant or award)
- 4 Open-market sale Porter Andy sold 260 shares at $33.10 ($8,606)
- 4 Open-market sale Senior Vice President, Finance sold 295 shares at $33.10 ($9,765)
- 4 Open-market sale Bergstrom Donald A sold 649 shares at $33.10 ($21,482)
- 4 Open-market sale General Counsel sold 295 shares at $33.10 ($9,765)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Senior Vice President, Finance sold 22,500 shares at $35.40 ($796,500)
- 4 Open-market sale General Counsel sold 6,500 shares at $35.42 ($230,230)
- 4 Open-market sale Bergstrom Donald A sold 30,000 shares at $34.15 ($1,024,500)
Page 13 of 16 · 320 filings